Sodium-glucose cotransporter 2 inhibitors as the first universal treatment of chronic kidney disease Usama Abdel Azim Sharaf El Din, Mona Mansour Salem, Dina Ossama Abdulazim

Type 2 sodium-glucose cotransporter (SGLT2) inhibitors: from familial renal glucosuria to the treatment of type 2 diabetes mellitus Pérez López, González Albarrán, Cano Megías

Severe hyperchloremic metabolic acidosis with SGLT2 inhibitors in patients with urinary diversion Carolina Gomes, João Barbosa Barroso, Ana Isabel Oliveira, Sofia Guerreiro Cruz, Liliana Cunha, Ana Azevedo